Genomics in acute lymphoblastic leukaemia: insights and treatment implications.
about
Drugs under preclinical and clinical study for treatment of acute and chronic lymphoblastic leukemiaGenetic abnormalities associated with acute lymphoblastic leukemiaComprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemiaRecent advances and novel treatment paradigms in acute lymphocytic leukemiaIL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing StudyCD19 Isoforms Enabling Resistance to CART-19 Immunotherapy Are Expressed in B-ALL Patients at Initial Diagnosis.High rates of submicroscopic aberrations in karyotypically normal acute lymphoblastic leukemia.Conditional Expression of E2A-HLF Induces B-Cell Precursor Death and Myeloproliferative-Like Disease in Knock-In Mice.Emergency medical genomes: a breakthrough application of precision medicine.Genome-Wide DNA Copy Number Analysis of Acute Lymphoblastic Leukemia Identifies New Genetic Markers Associated with Clinical Outcome.Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 ImmunotherapyBlood-based signatures in type 1 diabetes.Old and New Prognostic Markers in Pediatric ALL.Medulloblastoma Genotype Dictates Blood Brain Barrier Phenotype.Altered neutrophil immunophenotypes in childhood B‑cell precursor acute lymphoblastic leukemia.Novel dynamin 2 mutations in adult T-cell acute lymphoblastic leukemia.BIM mediates oncogene inactivation-induced apoptosis in multiple transgenic mouse models of acute lymphoblastic leukemia.BCR/ABL can promote CD19+ cell growth but not render them long-term stemness.High CRLF2 expression associates with IKZF1 dysfunction in adult acute lymphoblastic leukemia without CRLF2 rearrangement.Allogeneic Hematopoietic Stem Cell Transplantation with Myeloablative Conditioning Is Associated with Favorable Outcomes in Mixed Phenotype Acute Leukemia.Role of inotuzumab ozogamicin in the treatment of relapsed/refractory acute lymphoblastic leukemiaConserved IKAROS-regulated genes associated with B-progenitor acute lymphoblastic leukemia outcome.Ph-like acute lymphoblastic leukemia.Acute lymphoblastic leukemia in adolescents and young adults.Dysregulation of BCL-2 family proteins by leukemia fusion genes.IKZF1 alterations and expression of CRLF2 predict prognosis in adult Chinese patients with B-cell precursor acute lymphoblastic leukemia.Sleeping Beauty transposon screen identifies signaling modules that cooperate with STAT5 activation to induce B-cell acute lymphoblastic leukemiaRapid Capture Next-Generation Sequencing in Clinical Diagnostics of Kinase Pathway Aberrations in B-Cell Precursor ALL.CD27 expression and its association with clinical outcome in children and adults with pro-B acute lymphoblastic leukemia.Zebrafish in Translational Cancer Research: Insight into Leukemia, Melanoma, Glioma and Endocrine Tumor Biology.Heterogeneity in mechanisms of emergent resistance in pediatric T-cell acute lymphoblastic leukemia.Transcription-coupled genetic instability marks acute lymphoblastic leukemia structural variation hotspots.FAM53B truncation caused by t(10;19)(q26;q13) chromosome translocation in acute lymphoblastic leukemia.Spectrum of somatic mutations detected by targeted next-generation sequencing and their prognostic significance in adult patients with acute lymphoblastic leukemia.Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBP.B lymphoblastic leukemia/lymphoma: new insights into genetics, molecular aberrations, subclassification and targeted therapy.Genomic characterization of chromosome translocations in patients with T/myeloid mixed-phenotype acute leukemia.Investigating the biology of relapsed acute leukemia: Proceedings of the Therapeutic Advances for Childhood Leukemia & Lymphoma (TACL) Consortium Biology Working Group.Survival among children diagnosed with acute lymphoblastic leukemia in the United States, by race and age, 2001 to 2009: Findings from the CONCORD-2 study.Mutational status of NRAS, KRAS, and PTPN11 genes is associated with genetic/cytogenetic features in children with B-precursor acute lymphoblastic leukemia.
P2860
Q26744365-7D242BBC-602B-4B09-B43E-E03E78E1BFF5Q26753823-EF57BA57-542E-45F3-87DC-5A48395D291EQ27853385-74617E5F-9636-4290-9A3D-9748D02B0CFDQ28078076-07ED8249-8AF7-471C-9307-BA094DCE09B2Q28555124-A06C222C-A904-406F-96B8-D03A690268DAQ33655754-60B1DB46-F8F9-4E9C-9702-73BDA1FEEE1CQ35801603-2C480BF3-5397-48D2-B912-63A8CC8ACE7DQ35847141-84E4D484-A661-4AEF-B18D-C86ADD0FCF64Q35903049-4FDBB5EA-40DB-4786-B656-7E995070557CQ35922398-7E5A86A4-FFD6-44AB-8131-DE917E42556BQ36349583-CCA4EC20-228A-4773-852C-B992F39FF4C8Q36552481-3C8C91E4-2342-4E9E-8DF7-B99E1F514F91Q36679526-2677733D-8368-4A77-A586-A713CA2F7280Q36792016-51EC5EE2-6ADE-41C5-8C47-ED8F2AD7E47AQ37269402-B09F19DA-D72B-4733-BE61-8B78BFD3AFA2Q37287489-75A092CB-E644-4E0B-BBB3-4B342EADE26FQ37317126-BAE56217-B550-4099-B728-AF12A0B8C334Q37531026-F1EC468F-14A9-4C40-8BD5-B9A12C7EB4E6Q37580303-551458F7-6409-41B1-9B4C-B8CAFEF697C0Q38685482-2D432D70-200C-46B9-917A-A67DDCCA3865Q38701163-01E0E299-A5B4-4E99-9616-6510A9229778Q38716763-CE01580D-BCFF-4F6A-99E5-1194C3AF3DDFQ39027852-CB66B125-F0D7-4C7B-9F34-AD9EE3A59ED5Q39192991-C0CD2AD6-C612-4385-8536-E1EECB00DAD3Q39440247-16BEC1E5-8557-448F-A9BF-9C3A4C0DFE44Q39784866-D9E041C7-5F65-4F6D-B504-8407D8B48849Q40673870-B9A85D3B-C249-4AD2-B279-05A040A1148CQ40836915-5745256A-0805-4712-AA34-74F5AB61FCF0Q41080121-D04FF5FA-935B-43D2-95D2-0C5EB1CF15E0Q41673513-ED4133D2-3788-49FE-8970-F4D54420AE80Q41781135-533D2689-57DA-4FA3-AF85-7AAA50E100FFQ41880933-3DFC6340-9F05-4837-80A6-02388A3DC769Q42290646-9F94C2F2-502C-4B75-A532-F142CA0C0A53Q42319064-A85BB666-90B5-4D29-9D38-4847085FFAB0Q42324924-2D103A85-4508-4525-96D3-E6CAA9CA4739Q42371687-8A210832-EFF3-40FE-82B1-92E2C7A5D6D1Q42777609-A1EF3BD4-7765-4D19-A4FF-462AAB7FF91FQ46355299-1A1C3CE5-FC9F-4281-8E69-B6306FD62AA1Q46764633-6CC46268-32F7-42BB-AD93-3D9074404281Q47884832-AC1790A7-14FF-44D0-A6E3-9A56C2A5308E
P2860
Genomics in acute lymphoblastic leukaemia: insights and treatment implications.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Genomics in acute lymphoblastic leukaemia: insights and treatment implications.
@en
type
label
Genomics in acute lymphoblastic leukaemia: insights and treatment implications.
@en
prefLabel
Genomics in acute lymphoblastic leukaemia: insights and treatment implications.
@en
P2860
P1476
Genomics in acute lymphoblastic leukaemia: insights and treatment implications.
@en
P2093
Kathryn G Roberts
P2860
P304
P356
10.1038/NRCLINONC.2015.38
P407
P577
2015-03-17T00:00:00Z